Protocol First, a Salt Lake City software solutions provider focused on accelerating clinical research, will become a wholly owned subsidiary of Flatiron Health, the two companies announced in a joint release. Flatiron Health is a New York-based healthcare technology company that provides electronic health record systems, patient monitoring, clinical data management and related solutions for cancer centers.
“We are very excited about this combination, which will take our technology to the next level, scaling and broadening its availability across the life sciences industry,” said Protocol First CEO Hugh Levaux, who joins Flatiron as vice president of clinical research. “The transition will be seamless for our customers, and the future belongs to the patients we will all serve with even better solutions.”
“This is a win-win for both companies,” said Carolyn Starrett, Flatiron CEO. “Flatiron and Protocol First share a common vision in which technology and software increasingly bridge the gap between real-world care and clinical research.”
Protocol First employees and operations join Flatiron’s Clinical Research business unit.
“Flatiron has deep expertise in unstructured-data processing, experience building software that integrates seamlessly into site workflows and an engaged network of community and academic research sites,” said Alex Deyle, general manager of clinical research at Flatiron. “Protocol First’s technology expands and accelerates our ability to drive much-needed innovation in clinical research.”
Flatiron Health is an independent affiliate of the Roche Group and has over 2,500 employees nationwide.
